Having identified C4, we then performed more quantitative assays focusing on mutant RAS containing PANC-1 and Panc 04.03 (KRAS12D), MIA PaCa-2 (KRAS12C), and Capan1 (KRAS12V) pancreatic tumor cells. This evidence concerns the gene C4A and pancreatic neoplasm.